Next Generation News and Research

RSS

Intestinal bacteria in multiple sclerosis patients vary with disease activity, study finds

Multiple sclerosis patients do not have the same bacteria in their intestines as healthy people. There are also differences in the composition and function of the bacteria in the intestines of multiple sclerosis patients, depending on whether their illness is active, and whether they are in treatment.

5 Jan 2023

Insilico Medicine launches a 6th generation Intelligent Robotics Drug Discovery Laboratory

Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – a 6th generation Intelligent Robotics Drug Discovery Laboratory – in Suzhou BioBAY Industrial Park on Dec. 29.

5 Jan 2023

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim, one of the world-leading pharmaceutical companies developing innovative therapies for diseases with unsatisfactory treatments.

From PhoreMost 5 Jan 2023

Study assesses microbiome of male genital mucosa

A new study in the journal Microorganisms aimed to identify and analyze studies on the composition of the microbial community on different parts of the healthy and diseased male genital mucosa.

4 Jan 2023

Applicant numbers remain unchanged even after significant increase in plastic surgery residency positions

Historically plastic surgery has been considered one of most competitive and highly sought after residency programs.

30 Dec 2022

Health care is growing less affordable for U.S. adults with employer-sponsored health insurance, analysis finds

Health care is growing less affordable for U.S. adults - particularly women - with employer-sponsored health insurance, according to an analysis by researchers at the NYU School of Global Public Health published in the Journal of the American Medical Association.

27 Dec 2022

Insilico announces nomination of preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy

Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company's drug discovery team has nominated a preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy utilizing its end-to-end Pharma.AI platform.

27 Dec 2022

Xanthan gum-based fluid thickener can lower blood glucose levels after eating, study shows

Type 2 diabetes mellitus is a common lifestyle disease that is prevalent worldwide. It can often lead to complications, such as diseases of the heart, and increased risk of death, but preventive measures, such as a healthy diet, can reduce these risks.

27 Dec 2022

Preoptic neurons play key role in regulating body temperature in mammals, study shows

A research group at Nagoya University in Japan has reported that a group of neurons, called EP3 neurons, in the preoptic area of the brain play a key role in regulating body temperature in mammals.

23 Dec 2022

Brazilian model for COVID-19 vaccination reduced severe case and mortality even from variants

A study conducted in Serrana, a small town in São Paulo state used as a model for COVID-19 vaccination in Brazil, shows that mass vaccination reduced the severe case and death rates even while the gamma and delta variants were circulating.

21 Dec 2022

Using 3D patient tumor avatars to guide cancer treatment decisions

At any time, most cancer patients are receiving a treatment that does not significantly benefit them while enduring bodily and financial toxicity.

20 Dec 2022

Nasal antibodies decline nine months after COVID-19 infection, study finds

A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year.

20 Dec 2022

First cell-type specific multiomic study of the HIV brain

Researchers identify cell-type-specific differences in HIV integration sites in the brain.

19 Dec 2022

Study looks at self-reported physical health status of refugees, immigrants, and Canadian-born individuals

With the projected influx of refugees coming to Canada, particularly with global crises such as the war in Ukraine, it is imperative to understand the health outcomes of refugees who settle in Canada.

16 Dec 2022

High performing primary care practices for patients with diabetes during the pandemic

Published in PLOS ONE, University of Minnesota Medical School researchers explored how high performing primary care practices organized care for patients with diabetes during the first months of the COVID-19 pandemic.

16 Dec 2022

Next-generation sequencing could change research on sexual assault cases

In this interview, Alexis Garloff talks to NewsMedical about her next-generation sequencing research and the possible applications in forensics, particularly in sexual assault cases.

From Verogen, Inc. 16 Dec 2022

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

Researchers demonstrated the exceptional immune evasion properties of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, BQ and XBB.

16 Dec 2022

PhoreMost and ThinkCyte collaborate to advance AI based drug discovery

PhoreMost Ltd. and ThinkCyte K.K today announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).

From PhoreMost 16 Dec 2022

New clue may explain why women are at greater risk for Alzheimer's disease

Scientists at Scripps Research and Massachusetts Institute of Technology (MIT) have found a clue to the molecular cause of Alzheimer's - a clue that may also explain why women are at greater risk for the disease.

15 Dec 2022

Research: Patient's race may influence recommendations for surgical resection of brain tumors

Published in The Lancet, University of Minnesota Medical School researchers found a patient's race may influence recommendations for surgical removal of brain tumors.

15 Dec 2022

Next Generation News and Research

Intestinal bacteria in multiple sclerosis patients vary with disease activity, study finds

Insilico Medicine launches a 6th generation Intelligent Robotics Drug Discovery Laboratory

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

Study assesses microbiome of male genital mucosa

Applicant numbers remain unchanged even after significant increase in plastic surgery residency positions

Health care is growing less affordable for U.S. adults with employer-sponsored health insurance, analysis finds

Insilico announces nomination of preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy

Xanthan gum-based fluid thickener can lower blood glucose levels after eating, study shows

Preoptic neurons play key role in regulating body temperature in mammals, study shows

Brazilian model for COVID-19 vaccination reduced severe case and mortality even from variants

Using 3D patient tumor avatars to guide cancer treatment decisions

Nasal antibodies decline nine months after COVID-19 infection, study finds

First cell-type specific multiomic study of the HIV brain

Study looks at self-reported physical health status of refugees, immigrants, and Canadian-born individuals

High performing primary care practices for patients with diabetes during the pandemic

Next-generation sequencing could change research on sexual assault cases

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

PhoreMost and ThinkCyte collaborate to advance AI based drug discovery

New clue may explain why women are at greater risk for Alzheimer's disease

Research: Patient's race may influence recommendations for surgical resection of brain tumors

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News